MedPath

Vancomycin Hydrochloride

Vancomycin Hydrochloride for Injection, USP

Approved
Approval ID

f28e3c2b-ae31-4c2a-8178-53962b7b213c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 22, 2022

Manufacturers
FDA

BluePoint Laboratories

DUNS: 985523874

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Vancomycin Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68001-406
Application NumberANDA204125
Product Classification
M
Marketing Category
C73584
G
Generic Name
Vancomycin Hydrochloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateSeptember 22, 2022
FDA Product Classification

INGREDIENTS (1)

VANCOMYCIN HYDROCHLORIDEActive
Quantity: 5 g in 1 1
Code: 71WO621TJD
Classification: ACTIM

Vancomycin Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68001-407
Application NumberANDA204125
Product Classification
M
Marketing Category
C73584
G
Generic Name
Vancomycin Hydrochloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateSeptember 22, 2022
FDA Product Classification

INGREDIENTS (1)

VANCOMYCIN HYDROCHLORIDEActive
Quantity: 10 g in 1 1
Code: 71WO621TJD
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Vancomycin Hydrochloride - FDA Drug Approval Details